Drug – bio-affecting and body treating compositions – Inorganic active ingredient containing – Heavy metal or compound thereof
Reexamination Certificate
2007-08-14
2007-08-14
Pak, John (Department: 1616)
Drug, bio-affecting and body treating compositions
Inorganic active ingredient containing
Heavy metal or compound thereof
C424S602000, C424S641000, C424S675000, C424S678000, C424S681000, C424S682000, C424S683000, C424S686000, C424S687000, C424S688000, C424S692000, C424S693000, C424S696000, C424S697000, C424S722000, C514S249000, C514S251000, C514S345000, C514S419000, C514S474000, C514S494000, C514S553000, C514S556000, C514S561000, C514S563000, C514S567000, C514S578000, C514S809000, C514S811000, C514S812000
Reexamination Certificate
active
10977976
ABSTRACT:
Benzodiazepine withdrawal induced anxiety is treated by administration of an enkephalinase inhibitor, and a gamma-aminobutyric acid (“GABA”) precursor, or an endorphin or enkephalin releaser. These components promote restoration of normal neurotransmitter function and are non-addictive. Use of the enkephalinase inhibitor D-phenylalanine, the GABA precursor glutamine, the serotonin precursor 5-HTP, glycine, and taurine, in combination with coenzymatic functionality of folic acid is preferred for activation of ligand-gated Cl−channel in the central nervous system. Food supplement embodiments provide the human body nutritional supplements to intake certain neurotransmitter precursor substrates, thereby enabling patients of all ages to self-regulate their ability to quell perturbations to equilibrium and simultaneously to adverse effects upon normal physiological and psychological functioning attributable to induced anxiety and panic associated with benzodiazepine withdrawal.
REFERENCES:
patent: 4761429 (1988-08-01), Blum et al.
patent: 5189064 (1993-02-01), Blum et al.
patent: 5922361 (1999-07-01), Bieser et al.
patent: 6159506 (2000-12-01), Bieser et al.
patent: 6955873 (2005-10-01), Blum
patent: 2004/0116351 (2004-06-01), Halevie-Goldman
Medline abstract 93233833 (1993).
Bieser Albert Howard
Neher Terry Leo
Harrison Law Office
Pak John
LandOfFree
Enkephalinase inhibitor and GABA precursor loading as... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Enkephalinase inhibitor and GABA precursor loading as..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Enkephalinase inhibitor and GABA precursor loading as... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3837828